Castle Biosciences (CSTL) vs Lumexa Imaging (LMRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Lumexa Imaging is the larger company by market cap ($1.02 billion vs $1.01 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CSTL | LMRI |
|---|---|---|
| Share price | $33.00 | $10.59 |
| Market cap | $1.01B | $1.02B |
| 1-day change | -1.08% | -1.12% |
| YTD return | -15.17% | -42.76% |
| 1-year return | +43.98% | — |
| 5-year return | -48.10% | — |
| Forward P/E | — | 11.90 |
| EPS (TTM) | $-0.64 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $44.28 | $19.45 |
| 52-week low | $17.72 | $6.45 |
| Distance from 52-week high | -25.47% | -45.55% |
| Average volume | 402.13K | 431.61K |
| Shares outstanding | 30.55M | 96.07M |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CSTL vs LMRI FAQ
Which is bigger, Castle Biosciences or Lumexa Imaging?
Lumexa Imaging (LMRI) is larger, with a market capitalization of $1.02B compared with $1.01B for Castle Biosciences (CSTL).
Are Castle Biosciences and Lumexa Imaging in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.